Search research articles
Contact Us
Filters
Showing results (161-170 of 231) with videos related to
Page
of 24
Sort By:
The Journal of Pathology
|
August 25, 2016
Macrophage-mediated psoriasis can be suppressed by regulatory T lymphocytes
Rafael Leite Dantas, Dörthe Masemann, Tanja Schied, et al.
Biomacromolecules
|
July 7, 2025
Controlling the Sulfation Density of Glycosaminoglycan Glycopolymer Mimetics Enables High Antiviral Activity against SARS-CoV-2 and Reduces Anticoagulant Activity
Miriam Hoffmann, Lorand Bonda, Ines Fels, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
August 10, 2019
The annexin A1/FPR2 signaling axis expands alveolar macrophages, limits viral replication, and attenuates pathogenesis in the murine influenza A virus infection model
Sebastian Schloer, Nicole Hübel, Dörthe Masemann, et al.
Antiviral Research
|
June 19, 2007
A polyphenol rich plant extract, CYSTUS052, exerts anti influenza virus activity in cell culture without toxic side effects or the tendency to induce viral resistance
Christina Ehrhardt, Eike R Hrincius, Virginia Korte, et al.
The Journal of Infectious Diseases
|
November 22, 2011
Synergistic adaptive mutations in the hemagglutinin and polymerase acidic protein lead to increased virulence of pandemic 2009 H1N1 influenza A virus in mice
Roman Seyer, Eike R Hrincius, Dorothea Ritzel, et al.
The American Journal of Pathology
|
April 25, 2012
A single point mutation (Y89F) within the non-structural protein 1 of influenza A viruses limits epithelial cell tropism and virulence in mice
Eike R Hrincius, Ann-Katrin Hennecke, Lisa Gensler, et al.
Antiviral Research
|
April 19, 2020
Antiviral efficacy against influenza virus and pharmacokinetic analysis of a novel MEK-inhibitor, ATR-002, in cell culture and in the mouse model
Martin Laure, Hazem Hamza, Julia Koch-Heier, et al.
Molecular Therapy Oncolytics
|
November 29, 2023
Replication-incompetent influenza A viruses armed with IFN-γ effectively mediate immune modulation and tumor destruction in mice harboring lung cancer
Ramona Meissner, Viktor Wixler, Franziska Paulina Wulfert, et al.
Frontiers in Microbiology
|
November 23, 2017
Pharmacodynamics, Pharmacokinetics, and Antiviral Activity of BAY 81-8781, a Novel NF-κB Inhibiting Anti-influenza Drug
Karoline Droebner, Emanuel Haasbach, Sabine E Dudek, et al.
The Journal of Biological Chemistry
|
August 17, 2004
Dual function of interleukin-1beta for the regulation of interleukin-6-induced suppressor of cytokine signaling 3 expression
Xiang-Ping Yang, Ute Albrecht, Vera Zakowski, et al.
Page
of 24
Search research articles
Search
Showing results (161-170 of 231) with videos related to
Sort By:
Page
of 24
The Journal of Pathology
|
August 25, 2016
Macrophage-mediated psoriasis can be suppressed by regulatory T lymphocytes
Rafael Leite Dantas, Dörthe Masemann, Tanja Schied, et al.
Biomacromolecules
|
July 7, 2025
Controlling the Sulfation Density of Glycosaminoglycan Glycopolymer Mimetics Enables High Antiviral Activity against SARS-CoV-2 and Reduces Anticoagulant Activity
Miriam Hoffmann, Lorand Bonda, Ines Fels, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
August 10, 2019
The annexin A1/FPR2 signaling axis expands alveolar macrophages, limits viral replication, and attenuates pathogenesis in the murine influenza A virus infection model
Sebastian Schloer, Nicole Hübel, Dörthe Masemann, et al.
Antiviral Research
|
June 19, 2007
A polyphenol rich plant extract, CYSTUS052, exerts anti influenza virus activity in cell culture without toxic side effects or the tendency to induce viral resistance
Christina Ehrhardt, Eike R Hrincius, Virginia Korte, et al.
The Journal of Infectious Diseases
|
November 22, 2011
Synergistic adaptive mutations in the hemagglutinin and polymerase acidic protein lead to increased virulence of pandemic 2009 H1N1 influenza A virus in mice
Roman Seyer, Eike R Hrincius, Dorothea Ritzel, et al.
The American Journal of Pathology
|
April 25, 2012
A single point mutation (Y89F) within the non-structural protein 1 of influenza A viruses limits epithelial cell tropism and virulence in mice
Eike R Hrincius, Ann-Katrin Hennecke, Lisa Gensler, et al.
Antiviral Research
|
April 19, 2020
Antiviral efficacy against influenza virus and pharmacokinetic analysis of a novel MEK-inhibitor, ATR-002, in cell culture and in the mouse model
Martin Laure, Hazem Hamza, Julia Koch-Heier, et al.
Molecular Therapy Oncolytics
|
November 29, 2023
Replication-incompetent influenza A viruses armed with IFN-γ effectively mediate immune modulation and tumor destruction in mice harboring lung cancer
Ramona Meissner, Viktor Wixler, Franziska Paulina Wulfert, et al.
Frontiers in Microbiology
|
November 23, 2017
Pharmacodynamics, Pharmacokinetics, and Antiviral Activity of BAY 81-8781, a Novel NF-κB Inhibiting Anti-influenza Drug
Karoline Droebner, Emanuel Haasbach, Sabine E Dudek, et al.
The Journal of Biological Chemistry
|
August 17, 2004
Dual function of interleukin-1beta for the regulation of interleukin-6-induced suppressor of cytokine signaling 3 expression
Xiang-Ping Yang, Ute Albrecht, Vera Zakowski, et al.
Page
of 24